Attachment, proliferation and osteogenic response of osteoblast-like cells cultured on titanium...
-
Upload
elena-de-angelis -
Category
Documents
-
view
212 -
download
0
Transcript of Attachment, proliferation and osteogenic response of osteoblast-like cells cultured on titanium...
Attachment, Proliferation and Osteogenic Response ofOsteoblast-Like Cells Cultured on Titanium Treatedby a Novel Multiphase Anodic Spark Deposition Process
Elena De Angelis,1 Francesca Ravanetti,2 Antonio Cacchioli,2 Attilio Corradi,1 Carmen Giordano,3
Gabriele Candiani,3 Roberto Chiesa,3 Carlo Gabbi,2 Paolo Borghetti1
1 Pathology Unit, Department of Animal Health, Faculty of Veterinary Medicine, University of Parma, Parma, Italy
2 Anatomy Unit, Department of Animal Health, Faculty of Veterinary Medicine, University of Parma, Parma, Italy
3 Department of Chemistry, Materials and Chemical Engineering, Politecnico di Milano, Milan, Italy
Received 21 May 2007; revised 19 March 2008; accepted 9 April 2008Published online 7 August 2008 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/jbm.b.31179
Abstract: A new bioactive titanium surface treatment, labeled Ti-ASD, was developed using
the electrochemical anodic spark deposition (ASD) technique and results in a thickened
titanium oxide layer with higher levels of calcium and phosphorus typical of newly deposited
mineral phase. This study was aimed at extending the knowledge on Ti-ASD treatment, by
means of evaluation of the attachment, morphology, proliferation, metabolic activity,
differentiation, and mineralization of osteoblast-like cells (SaOS-2) after growth on Ti-ASD
treated titanium compared with nontreated titanium (Ti) and with chemically etched titanium
(Ti-ETC). This novel type of titanium coating supported cell attachment, cell proliferation,
and mineralization, revealing no cytotoxicity effects. The expression of differentiation markers
on Ti-ASD treated titanium shows that genes related to the proliferation phase (Collagen type
I, Coll I; Cbfa-1) were early expressed, whereas genes related to the mineralization phase
(alkaline phosphatase, osteopontin, bone sialo protein) increased in a time-related way.
Mineralization occurred on all analyzed surfaces, but on Ti-ASD the number of bone-like
nodules and the amount of mineralized area was higher. In conclusion, Ti-ASD resulted to be a
good surface for osteoblast attachment and proliferation, also promoting the maintenance of
cell differentiation and matrix mineralization, a fundamental requirement for sustain the
osseointegration and the clinical success of dental implants. ' 2008 Wiley Periodicals, Inc. J Biomed
Mater Res Part B: Appl Biomater 88B: 280–289, 2009
Keywords: titanium; surface treatment; human osteoblast-like cells; attachment; differ-
entiation
INTRODUCTION
For clinically successful implants, interaction between
implanted materials and surrounding tissue is critical.
Osseointegration is the condition in which mature bone is
deposited on implant without any interposed soft or fibrous
tissue. For dental and orthopedic application, a basic require-
ment for osseointegration is the type of interaction between
implant surface and the surrounding tissue. The bone pro-
vides a dynamic interface in continuous evolution1,2 and
then the osseointegration process is complex and involves
numerous factors in which a key role is played by topogra-
phy and chemistry of the implant surface3; a suitable surface
for osseointegration should first promote cell attachment,
and then sustain cell proliferation, maintain cell differentia-
tion, and improve extracellular matrix secretion.2 While dif-
ferentiation into bone-forming cells is the final parameter for
a good material–cell contact, the first period of implantation
is very important for cell attachment to the surface. In vitromodels, using cell culture, provide useful information relat-
ing to cell–biomaterial interaction.4,5 Cell culture parameters
(cell attachment, cell proliferation, differentiation markers,
matrix mineralization) can be used to screen in vitro syn-
thetic biomaterials prior to in vivo testing.
One of the main aims of the materials research for
implantology is related to the study and development of
surface modification techniques to improve the bone inte-
gration of titanium-based dental implants. Several mechani-
Correspondence to: E. De Angelis (e-mail: [email protected])Contract grant sponsor: MIUR (COFIN 2002 and COFIN 2004)
' 2008 Wiley Periodicals, Inc.
280
cal, chemical, and electrochemical techniques are currently
used to improve the surface of dental implants: acid etch-
ing, electropolishing, electrochemical treatments such as
anodic oxidation, sand blasting, and plasma spraying.6,7
A new bioactive titanium surface treatment, labeled Ti-
ASD, was developed using the electrochemical anodic
spark deposition (ASD) technique8,9: Ti-ASD treatment
involves the sequence of two ASD treatments followed by
a final alkali etching. The treatment is capable to properly
modify the superficial titanium oxide film. Ti-ASD treat-
ment results in a thickened titanium oxide layer with higher
levels of calcium and phosphorus. This layer was proven to
show excellent mechanic stability, high mineralization
potential, preferential protein adsorption, and high potenti-
ality in stimulating osteoblast activity.10,11
This study was aimed at extending the knowledge on
Ti-ASD treatment, by means of evaluation of the attach-
ment, morphology, metabolic activity, proliferation, differ-
entiation, and mineralization of a osteoblast cell line
(SaOS-2)12 after growth on Ti-ASD treated titanium com-
pared with non-treated titanium, labeled Ti, and with
chemically etched titanium, labeled Ti-ETC. Osteoblast dif-
ferentiation was analyzed by gene expression of specific
markers of osteoblast phenotype: collagen type I (Coll I)
which is associated with formation of the extracellular ma-
trix in proliferative step, alkaline phosphatase (ALP) which
is expressed during the first phase of the matrix maturation
step, osteopontin (OPN) which is expressed during the ma-
trix maturation step, bone sialo proteins (BSPs) and osteo-
calcin (OC) which are expressed in the mineralization
step.13,14 A key regulator of osteoblast differentiation is the
transcription factor Runx2 (core-binding factor 1, Cbfa1)15;
Runx2 binds to the osteoblast-specific cis-acting element 2
(OSE2), found in the promoter regions of all the major
osteoblast-specific genes (ALP, OPN, OC), and controls
their expression.16
MATERIALS AND METHODS
Preparation of Samples
All titanium specimens (3.0 cm 3 2.5 cm 3 1 mm) were
obtained from a commercially pure, grade 2 titanium sheet
(Torresin Titanio Metalli S.r.l., Padova, Italy). Three differ-
ent titanium surface treatments were investigated in this
study: (a) untreated, machined titanium, Ti, was used as a
control material; (b) chemically treated titanium, Ti-ETC,
resulting from a decontamination by strong alkali etching
followed by a double-step acid etching: the first step
carried out in 1M NaOH containing 2% H2O2 at 808C for
10 min, the second one in an acid water solution at 288Cfor 1 h; (c) electrochemically treated titanium, Ti-ASD,10
was prepared in an electrochemical cell through two con-
secutive ASD treatments, the first one performed in a solu-
tion containing calcium and phosphate ions and the second
one in a solution containing calcium ions alone. A final
treatment in concentrated potassium hydroxide water solu-
tion at 608C was then performed. Materials were treated
and supplied by the Department of Chemistry, Materials
and Chemical Engineering ‘‘G.Natta,’’ Politecnico di Mi-
lano, Milano, Italy. Before use, materials were sterilized by
rinsing them twice in pure ethanol for 30 s, washed in ster-
ile bidistilled H2O, and then dried in a laminar flow hood.
Cell Culture
Human SaOS-2 cells (provided by Cell Culture Laboratory,
Istituto Zooprofilattico Sperimentale della Lombardia e del-
l’Emilia Romagana ‘‘Bruno Ubertini,’’ Brescia, Italy; Experi-
mental Institute of Zooprophylaxis of Brescia, Italy) were
cultured in McCoy’s 5A medium containing 15% fetal calf
serum (FCS), 100 U/mL penicillin, and 0.1 mg/mL strepto-
mycin. Cells were seeded on the three different titanium sur-
faces at the density of 2 3 104 cells/cm2. Incubation was
carried out at 378C in a humidified atmosphere of 5% CO2
in air for the time specified for each single experiment.
Scanning Electron Microscopy
Scanning electron microscopy (SEM) observation was per-
formed after 6, 24, 48 h, and 4 days of culture. Culture for
SEM analysis was performed in triplicate. Cells grown on
different titanium surfaces were fixed at each selected time
point with 2.5% glutaraldehyde in 0.1M sodium cacodylate
buffer (pH 5 7.3) for 2 h at 48C. They were then dehy-
drated through a series of alcohols and then critical point
dried with liquid carbon dioxide (CPD 030 Baltec, Wallruf,
Germany). Specimens were then sputter-coated (Balzers de-
vice) with gold-palladium (Plano, Germany) using a SCD
040 coating device (Balzer Union, Wallruf, Germany).
Samples were observed using a Zeiss DSM 950 scanning
electron microscope at an accelerating voltage of 10 kV
(Zeiss, Jena, Germany).
Cell Attachment, Cell Proliferation, and Cell Viability
For the evaluation of cell proliferation, cells were cultured
on materials for 1, 2, 4, and 7 days. The 1-day time-point
was used to evaluate cell attachment. At each time point, af-
ter medium removing, surfaces were washed with PBS and
then incubated with trypsin (0.1% trypsin – 0.02% EDTA
(Sigma-Aldrich, St. Louis, MO) for 7 min to obtain cell
detachment. Obtained cells were counted by Burker’s hemo-
cytometer. For cell viability evaluation, detached cells were
incubated for 5 min with Trypan blue and then counted.
Complete removal of the attached cells from the surfaces
with trypsin-EDTA was confirmed by SEM. Values reported
in the graph represent the mean 6 standard deviation of
three independent analyses performed in triplicates.
281GROWTH OF OSTEOBLAST-LIKE CELLS ON ASD-TREATED TITANIUM
Journal of Biomedical Materials Research Part B: Applied Biomaterials
MTT Assay
Cell viability was also evaluated by measuring the mito-
chondrial dehydrogenase activity using a modified MTT (3-
(4,5-dimetyl-2-tiazolyl)-2,5-diphenyl-2H-tetrazolium bro-
mide) reduction assay. Briefly, the cells on days 1, 2, 4,
and 7 after seeding on the titanium surfaces were incubated
with 600 lL McCoy’s 5A and 60 lL MTT (Sigma-Aldrich;
Cat. No. M2128), 5 mg/mL in PBS for 4 h at 378C. Then,600 lL of 10% SDS in 0.01M HCl was added and incu-
bated overnight at 378C. The resulting solution was moved
into fresh plates and the absorbance was measured using
Spectra Shell Microplate Reader (SLT, TECAN, Milan,
Italy) at a wavelength of 540 nm (the reference value was
690 nm). Three titanium surfaces without cells incubated
with medium and MTT was used as control samples
(blank).
mRNA Isolation and RT-PCR
Total RNA was extracted with a RNAwiz kit (Ambion,
Austin, TX), according to manufacturer’s instruction, from
cell samples after 4 and 7 days of culturing and then spec-
trophotometrically quantified. Two micrograms of total
RNA was used for reverse-transcribing to cDNA using
‘‘Ready-To-Go You-Prime First-Strand Beads’’ (GE Health-
care, Uppsala, Sweden) in a reaction volume of 33 lL.Obtained cDNA was used as a template for polymerase
chain reaction with specific primers for Cbfa1, type I colla-
gen, ALP, OPN, and BSPs. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was used as housekeeping gene
(Table I). Five microliters of cDNA was amplified using
DyNAZyme II DNA polymerase Recombinant (Ambion),
and 5 lL of both forward and reverse primers (25 lM).
The PCR products were separated by electrophoresis in a
2% agarose gel in Tris-acetate-EDTA buffer and visualized
by ethidium bromide staining under UV light. The density
of each band was quantified by densitometric analysis with
Scion Image (Scion Capture Driver 1.2 for Image-Pro Plus;
Scion, MA).
Mineralization Staining (Alizarin Red S)
Human SaOS-2 cells were plated in triplicate at the density
of 2 3 104 cell/cm2 onto prepared titanium samples. Cells
were cultured in osteogenic culture medium, which consists
of McCoy’s 5A medium, 15% FCS, 100 U/mL penicillin,
0.1 mg/mL streptomycin, 250 lM L-ascorbic acid, 10 mMb-glycerophosphate, and 10 nM of dexamethasone. Also,
control samples (each biomaterial without cells and with
osteogenic medium) were run. After 21 days of culture,
Alizarin Red staining was performed. Cells were washed
twice with PBS and fixed in 4% paraformaldehyde in 0.1MPBS for 20 min at room temperature and then rinsed once
with deionized water. After fixation, the cultures were
stained with 2% solution of Alizarin Red S in 0.1M PBS
for 5 min at room temperature. Excess dye was washed off
with deionized water. Samples were visualized through a
microscopy (Nikon SMZ1000; Nikon, Tokyo, Japan). The
titanium area covered with a red stain, representing miner-
alized bone-like nodules, was then measured with an image
analysis system (Laboratory Universal Computer Image
Analysis-LUCIA G, Version 5.0, Laboratory Imaging,
Prague, Hungary). For the evaluation of mineralization pat-
tern, the number of nodules, the area of titanium surface
covered by each single bone nodule (bone-nodule area),
and the total area of titanium surface covered by the bone
nodules (total bone-nodules area) were measured.
Statistical Analysis
Using a statistical software program (SPSS, Chicago, IL)
for the variance test (ANOVA) and Tukey’s multiple com-
parison test post hoc, data were analyzed to highlight any
significant differences between surface treatments. Statisti-
cally significant differences (p \ 0.05 or p \ 0.001) were
indicated in the text, figures, and table.
TABLE 1. Oligonucleotide Primers for Gene Expression Analysis by RT-PCR
Gene Primer Sequence Tm (8C)
Expected
Product
Size (bp)
ALP Sense: 50 GCG AAA GTA TTT CTC CAG ACC CAG 30 64.4 367
Antisense: 50 TTC CAA ACA GGA GAG TCG CTT CAA 30
OPN Sense: 50 TGA GAG CAA TGA GCA TTC CGT TG 30 60.6 330
Antisense: 50 CAG GGA GGT TCC ATG AAG CAA C 30
Cbfa1 Sense: 50 CTC TTC CCA AAG CCA GAG TG 30 59.4 205
Antisense: 50 CAG CGT CAA CAC CAT CAT TC 30
Type I Collagen Sense: 50 CCT CAA GGG CTC CAA CGA G 30 57.3 117
Antisense: 50 TCA ATC ACT GTC TTG CCC CA 30
BSP Sense: 50 ATT GAA AAC GAA AGC GAA G 30 51.5 450
Antisense: 50 ATC ATA GCC ATC GTA GCC TTG T 30
GAPDH Sense: 50 GAA GGT GAA GGT CGG AGT C 30 45 224
Antisense: 50 GAA GAT GGT GAT GGG ATT TC 30
282 DE ANGELIS ET AL.
Journal of Biomedical Materials Research Part B: Applied Biomaterials
RESULTS
Scanning Electron Microscopy
All titanium surface treatments supported cell adhesion and
proliferation; however, this process showed different dy-
namics related with the peculiar surface topography of each
material. Cells began to adhere and spread on the materi-
als’ surfaces within a short time after being seeded. After 6
h (Figures 1 and 2), SaOS-2 cells were adherent with an
heterogeneous morphology: some cells were elongated,
other polygonal or rounded. Cells mostly presented a typi-
cal morphology of osteoblast, a central spherical body with
the cytoplasm extending away from the central area in all
directions and adhering to the titanium surfaces with fila-
mentous protrusions.
After 4 days on Ti and Ti-ETC, cells covered the mate-
rial uniformly with an almost confluent monolayer. Particu-
larly, on Ti-ETC, (Figure 2) the cells prevalently had a
polygonal shape, with many adhesion points at the surface,
creating a spreading of cells and presenting a more flat-
tened morphology than that of cells growing on Ti. After 4
days of culturing, cells were tightly flattened and single
cells were difficult to distinguish from each other.
After 24 h on Ti-ASD surface (Figure 3), cells were still
relatively spread on the surface, and presented a rounded
morphology with many cytoplasmic processes extended
from cytoplasm to material surface. After 48 h, cells had
increased the extent of cell spreading and appeared homo-
geneously attached on Ti-ASD but still inconfluent and
with few intercellular contacts. After 4 days, cells were
extensively spread, exhibiting a highly flattened morphol-
ogy. Cells were frequently attached to each other with
scarce intercellular gaps, forming a regular monolayer. At
each time point cells grown on Ti-ASD presented many ap-
ical ruffles, testifying a high cellular activity.17 On Ti and
Ti-ETC this aspect was less evident and it appeared only
within 48 h after seeding.
Cell Attachment and Cell Proliferation
Cell attachment, evaluated 1 day after seeding, turned out
to be similar on Ti and Ti-ETC, while the number of cells
Figure 1. SEM morphology (magnification 3640) of SaOS-2 cells after 6, 24, 48 h, and 4 days of
growing on titanium Ti.
283GROWTH OF OSTEOBLAST-LIKE CELLS ON ASD-TREATED TITANIUM
Journal of Biomedical Materials Research Part B: Applied Biomaterials
attached on Ti-ASD was statistically significantly lower
(Ti-ASD vs Ti and Ti-ETC, p \ 0.05) as shown in Figure
4. On all titanium surfaces the cell proliferation rate
increases in a time-related way with similar kinetics
(Figure 4); however, after 2, 4, and 7 days of culture, cell
numbers resulted higher on Ti and Ti-ETC than on Ti-
ASD. Particularly, at 2 days Ti-ETC compared with Ti-
ASD results statistically significant (p\ 0.05), at 4 days Ti
compared with Ti-ASD results statistically significant (p 50.05), and at 7 days Ti and Ti-ETC compared with Ti-ASD
results statistically significant (Ti-ASD vs Ti and Ti-ETC
p \ 0.05). Cell viability was evaluated by Trypan Blue
assay; results were similar at each time point on Ti, Ti-
ETC, and Ti-ASD: at least 95% of recovered osteoblasts
was viable (data not shown).
MTT Assay
The metabolic activity, measured by MTT assay, was nor-
malized for the cell numbers counted on the surfaces at each
time point (Figure 5). At all time points the metabolic activ-
ity of cells resulted higher on Ti-ASD when compared with
Ti-ETC and Ti (at 1 day: Ti-ASD vs Ti and Ti-ETC, p \0.05; at 2, 4, and 7 days: Ti-ASD vs Ti and Ti-ETC, p \0.001). With time, the metabolic activity of cells on Ti and
TI-ETC presented a similar trend characterized by an
increase at 2 days, but statistically significant for Ti-ETC (1
vs 2 days, p \ 0.001) because only for Ti-ETC it kept high
up to 4 days (1 vs 4 days, p \ 0.001), with a subsequent
decrease at 4 days for Ti (2 days vs 4 and 7 days, p \0.001) and a slightly delayed decrease for Ti-ETC (7 days vs
2 and 4 days, p \ 0.001). Only at 4 days there was differ-
ence between Ti and Ti-ETC (Ti vs Ti-ETC, p \ 0.001). At
2 days, on Ti-ASD the metabolic activity statistically signifi-
cantly increased, and then beginning to slowly decrease (1
day vs 2 and 4 days, p \ 0.001; 2 days vs 4 and 7 days,
p\ 0.001; 4 days vs 7days, p\ 0.001); at 4 days the cellu-
lar metabolic activity was lower when compared with the
value reached at 2 days, but still high, and finally at 7 days it
turned out comparable with the 1-day time-point.
Figure 2. SEM morphology (magnification 3640) of SaOS-2 cells after 6, 24, 48 h, and 4 days of
growing on titanium Ti-ETC.
284 DE ANGELIS ET AL.
Journal of Biomedical Materials Research Part B: Applied Biomaterials
RT-PCR
The analysis and quantification of mRNA expression for
specific osteoblast markers was carried out by reverse tran-
scription PCR after 4 and 7 days of SaOS-2 cells culture
on Ti, Ti-ETC, and Ti-ASD. Specific osteoblast markers
Cbfa-1, ALP, OPN, BSP, and type I collagen were used.
Data showed that Cbfa-1, type I collagen, ALP, OPN,
and BSP were expressed in all samples at each experimen-
tal time although there are some differences in the genes’
expression (Figure 6) as pointed out by densitometric anal-
ysis (Figure 7). The Cbfa-1 expression resulted similar on
the different surfaces (Ti, Ti-ETC, Ti-ASD) at each time
point. The ALP was expressed in all samples at each time:
after 4 days of culture ALP expression ended up being sim-
ilar for cells growing on Ti and Ti-ETC, whereas it was
lower for cells growing on Ti-ASD (Ti-ASD vs Ti and Ti-
ETC, p \ 0.001). Nevertheless, after 7 days of culture,
ALP expression on Ti-ASD increased (Ti-ASD: 4 days vs
7 days, p \ 0.001) and turned out to be similar among the
materials Ti, Ti-ETC, and Ti-ASD. The analysis of type I
collagen expression on testing materials showed no striking
differences at each experimental time; however, after 4
days of culture on Ti and Ti-ETC, type I collagen expres-
sion turned out to be lower compared with Ti-ASD (Ti-
ASD vs Ti and Ti-ETC, p \ 0.001), whereas at 7 days Ti
and Ti-ETC reached the Ti-ASD value (Ti: 4 days vs 7
days, p \ 0.001; Ti-ETC: 4 days vs 7 days, p \ 0.001).
After 4 days of culture, OPN expression resulted to be
lower on Ti and Ti-ASD compared with Ti-ETC (Ti-ETC
vs Ti and Ti-ASD, p\ 0.001), but after 7 days it had risen
to the level recorded on Ti-ETC (Ti: 4 days vs 7 days, p\0.001; Ti-ASD: 4 days vs 7 days, p \ 0.001), which
showed no change. The expression of BSPs mRNA was
higher on Ti-ASD than on Ti and Ti-ETC after 4 days (Ti-
ASD vs Ti and Ti-ETC p \ 0.001), although differences
among the tested materials were not detectable after 7 days
because the BSP expression on Ti and Ti-ETC had risen to
the level recorded on Ti-ASD (Ti: 4 days vs 7 days, p \0.001; Ti-ETC: 4 days vs 7 days, p\ 0.001).
Mineralization Staining
Mineralization of extracellular matrix was evaluated after
Alizarin Red staining and quantified by the image analysis
Figure 3. SEM morphology (magnification 3640) of SaOS-2 cells after 6, 24, 48 h, and 4 days
growing on titanium Ti-ASD.
285GROWTH OF OSTEOBLAST-LIKE CELLS ON ASD-TREATED TITANIUM
Journal of Biomedical Materials Research Part B: Applied Biomaterials
program (LUCIA G). The number of nodules, the area of
titanium surface covered by a bone nodule, and the total
area of titanium surface covered by the bone nodules were
measured (Table II). Bone-like nodules formation occurred
on all titanium surfaces but not on the negative control
samples (Figure 8). On Ti-ASD surface, the number of the
nodules was significantly higher when compared with Ti
(p \ 0.001) and Ti-ETC (p \ 0.001). The bone nodule
area on Ti-ASD and Ti-ETC surfaces resulted statistically
significantly lower when compared with Ti (Ti vs Ti-ASD,
p \ 0.001; Ti vs Ti-ETC, p \ 0.001). On Ti-ASD, an
increase in the amount of total nodules area was detected,
but it was not statistically significant when compared with
Ti and Ti-ETC. In conclusion, the mineralization pattern
had different dynamics on the three tested surfaces; particu-
larly, on Ti surface few and big nodules were present,
whereas on Ti-ETC and Ti-ASD surfaces numerous smaller
nodules were detectable.
DISCUSSION
In this study, osteoblast-like cell adaptation on three differ-
ent titanium surface treatments (Ti, Ti-ETC, Ti-ASD) was
tested. Cellular attachment, metabolic activity, proliferation,
differentiation, and mineralization were analyzed as param-
eters to characterize cell–biomaterial interaction.
SaOS-2 cells and other osteoblast-like cell lines are usu-
ally used to evaluate potential biomaterials in in vitro stud-
ies. This cell line expresses genes related to the
osteogenesis process, representing a useful model for the
evaluation of differentiation, matrix production, and miner-
alization. This provides useful information relating to cell–
biomaterial interaction and bone formation on the implant
surface.
In this study, cell attachment results to be similar on Ti
and Ti-ETC, whereas the number of cells attached on Ti-
ASD after 24 h was lower. The growth curves did not
achieve a plateau phase indicating no cytotoxic effects but
a good proliferation rate, and suggested similar kinetics on
the different titanium surfaces. However, cell proliferation
analysis showed that on Ti and Ti-ETC samples cell
growth was higher compared with Ti-ASD samples. These
Figure 6. Figure shows Cbfa-1, Collagen type I, ALP, OPN, BSP,
and GAPDH expression of the cells grown on Ti, Ti-ETC, Ti-ASD af-ter 4 and 7 days analyzed by RT-PCR (representative case).
Figure 4. Cell proliferation expressed as cell number 3 104/sample
(7.5 cm2) at 1, 2, 4, and 7 days of culture. Data are reported asmean 6 standard deviation (n 5 3). Tukey’s multiple comparison
test post hoc between tested surfaces for each experimental time:
*At day 1 Ti-ASD versus Ti and Ti-ETC (p\ 0.05); **at day 2 Ti-ASDversus Ti-ETC (p\ 0.05); 8at day 4 Ti versus Ti-ASD (p 5 0.05); 88atday 7 Ti-ASD versus Ti and Ti-ETC (p\ 0.05).
Figure 5. MTT assay expressed as optical density at 1, 2, 4, and 7
days of culture normalized for cell number counted on materials
at each time point. Data are reported as mean 6 standard deviation
(n 5 3). Tukey’s multiple comparison test post hoc between testedsurfaces for each experimental time: *At day 1 Ti-ASD versus Ti and
Ti-ETC (p \ 0.05); **at days 2, 4, and 7 Ti-ASD versus Ti and Ti-
ETC (p\ 0.001). Tukey’s multiple comparison test post hoc betweenexperimental times for each tested surface: Ti: a2 days versus 4 and
7 days (p\ 0.001); Ti-ETC: b1 day versus 2 and 4 days (p\ 0.001);c7 days versus 2 and 4 days (p \ 0.001); Ti-ASD: d1 day versus 2
and 4 days (p \ 0.001); e2 days versus 4 and 7 days (p\ 0.001); f4days versus 7 days (p\ 0.001).
286 DE ANGELIS ET AL.
Journal of Biomedical Materials Research Part B: Applied Biomaterials
data are in contrast with those of Giordano et al.,18 which
indicated a more flattened cellular morphology with cell
filopodia and a much higher activity for the cells cultured
on Ti-ASD, suggesting a more advanced attachment state
and proliferation activity on Ti-ASD surface. The described
discrepancy could be due to the different cell line used: it
is well known in literature that different cell lines respond
in different ways to the same surface features.19
Figure 7. Densitometric analysis of PCR product normalized with the GAPDH corresponding value.
Results are expressed as relative arbitrary units (RAU). Tukey’s multiple comparison test post
hoc between tested surfaces for each experimental time: *At day 4 Ti-ASD versus Ti and Ti-ETC
(p \ 0.001); **at day 4 Ti-ETC versus Ti and Ti-ASD (p \ 0.001). Tukey’s multiple comparison testpost hoc between experimental times for each tested surface: Ti: a4 days versus 7 days (p \ 0.001);
Ti-ETC: b4 days versus 7 days (p\ 0.001); Ti-ASD: c4 days versus 7 days (p\ 0.001).
TABLE 2. Data Regarding Bone-Like Nodules Formation in Cell Culture onto Ti, Ti-ETC, and Ti-ASD
Ti Ti-ETC Ti-ASD
Number of nodules/cm2 9.00 6 2.00 24.67 6 3.51 51.67 6 5.51*
Bone-nodule area (lm2) 30,895.24 6 782.13** 9503.26 6 5441.00 7011.02 6 4085.89
Total bone-nodules area (lm2) 277,139.28 6 50,966.26 232,612.80 6 30,215.32 364,981.02 6 42,572.53
Values represent the mean 6 standard deviation of triplicate analyses. Tukey0s multiple comparison test post hoc between tested surfaces: *Ti-ASD versus Ti and Ti-ETC
(p\ 0.001); ** Ti versus Ti-ETC and Ti-ASD (p\ 0.001).
287GROWTH OF OSTEOBLAST-LIKE CELLS ON ASD-TREATED TITANIUM
Journal of Biomedical Materials Research Part B: Applied Biomaterials
The MTT analysis confirms that no cytotoxicity effect
was present in cells grown on Ti- ASD compared with Ti
and Ti-ETC. Cells grown on Ti-ASD demonstrated not
only a good vitality but, moreover, a higher metabolic ac-
tivity. The differences in the cell number among Ti-ASD
and the other two tested titanium surfaces is not caused by
cell death on Ti-ASD but by a lower proliferation on this
surface. The higher metabolic activity observed on this ma-
terial was probably due to a major matrix proteins produc-
tion (Collagen Type I, BSPs).
Several studies suggested that materials being able to pro-
mote an early cell attachment and a good proliferation rate
are not necessarily the best substrates on which differentia-
tion can occur at all.20,21 Meyer et al.21 demonstrated that
the material property being responsible for the different rates
of attachment is not the same as that influencing differentia-
tion on the material. Consequently, to test new biomaterials
it is important to study both cell attachment to biomaterials
and proliferation kinetics in relation to their subsequent dif-
ferentiation. The osteoblasts developmental sequence, associ-
ated to bone cell differentiation, started with a period of
active proliferation but showed a slow down in the cell divi-
sion rate accompanying an increase in the amount of matrix
production (a signal of differentiation).22 For the evaluation
of these aspects RT-PCR analysis of genes related to the
osteogenesis process was carried out.
Cbfa-1 is a transcription factor of genes related to the
osteogenesis process23; its expression turned out to be simi-
lar on the different surfaces tested in this study, thus sug-
gesting that osteogenic efficiency of cells was maintained
in each condition. Type I collagen, an essential matrix pro-
tein, plays a fundamental role in the maintenance of osteo-
blastic phenotype making the matrix competent for
mineralization. Results showed a similar expression on
each tested material testifying a specific extracellular ma-
trix production. The ALP is expressed during the osteoblast
proliferation phase and it reaches the highest enzymatic ac-
tivity in the mineralization process, where it plays a key
role. After 4 days of culture, ALP expression was slightly
lower for cells growing on Ti-ASD compared with the
other materials; however, after 7 days of culture, it ended
up being similar between Ti-ASD and the other materials.
OPN is a matrix protein with different functions. It plays a
primary role in regulating mineralized bone formation and
remodeling.24 OPN synthesis is related with ALP activity,
because ALP removes a phosphate group from glycerol
phosphate which enters into the cell and upregulates OPN
mRNA expression.25 In accordance with this evidence, our
results indicate that OPN expression is comparable with
ALP expression. Particularly, after 4 days of culture, OPN
expression resulted to be slightly higher for cells growing
on Ti-ETC compared with the other materials. After 4 days
of culture the BSP expression was slightly higher for cells
growing on Ti-ASD compared with other materials. How-
ever, after 7 days of culture, it ended up reaching similar
levels in BS and in the other materials. These results sug-
gest a more differentiated state of SaOS-2 cells grown on
Ti-ASD in comparison with cells grown on the other
materials; in fact, its expression is tightly associated
to bone mineralization participating in the nucleation of
hydroxyapatite.26
Obtained results show that the gene expression of Cbfa-
1, ALP, OPN, BSP, and type I collagen were positively
regulated by titanium surface treatments. Particularly, the
expression of differentiation markers on Ti-ASD treated ti-
tanium shows that genes related to the proliferation phase
(Coll I, Cbfa-1) were early expressed. Whereas genes
related to the mineralization phase (ALP, OPN, and BSP)
increased in a time-related way. Although SaOS-2 cells lost
the stringent control between proliferation and differentia-
Figure 8. Mineralization pattern, obtained with Alizarin Red S stain, of SaOS-2 cells grown on Ti,
Ti-ETC, and Ti-ASD (a) and the negative control samples of these surfaces without cells (b). [Color
figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
288 DE ANGELIS ET AL.
Journal of Biomedical Materials Research Part B: Applied Biomaterials
tion22 when grown on Ti-ASD titanium, they showed a
progressive expression of genes associated with bone cell
differentiation similarly to the development sequence of the
normal osteoblasts.
The final differentiation parameter for osteoblast-like
cells is the formation of a calcified extracellular matrix;
related to biomaterials, the amount of mineralized matrix
formed on a material is the most reliable way to compare
the osteoinductive capacity of materials.27 Mineralization
occurred on all analyzed surfaces, but on Ti-ASD the num-
ber of bone-like nodules and the amount of mineralized
area was higher. This is in accordance with the results of
other authors11 who observed that Ti-ASD has an intrinsic
osteogenic activity because this surface may be recognized
by the cell as an environment being similar to that of a
bony tissue in its phase of repair for the high Ca/P ratio,
typical of newly deposited mineral phase.
In conclusion, Ti-ASD resulted to be a good surface for
osteoblast attachment and proliferation, also promoting the
maintenance of cell differentiation and matrix mineraliza-
tion, a fundamental requirement to sustain osseointegration
and the clinical success of dental implants.
REFERENCES
1. Albrektsson T, Zard G, Worthington P, Eriksson AR. Thelong-term efficacy of currently used dental implants. A reviewof proposed criteria of success. Int J Oral Maxillofac Implants1986;1:11–25.
2. Anselme K. Osteoblast adhesion on biomaterials. Biomaterials2000;7:667–681.
3. Wenneberg A, Albrektsson T, Johansson C, Andersson B. Ex-perimental study of turned and grift-blasted screw-shapedimplants with special emphasis on effect of blasting materialand surface topography. Biomaterials 1996;17:15–22.
4. Saad B, Casotti M, Huber TH, Schmutz P, Welti M, Uhl-schimd GK, Neuenschwander P, Suter UW. In vitro evalua-tion of the biofunctionally of osteoblasts cultured on DegraPol-foam. J Biomater Sci Polym Ed 2000;11:787–800.
5. Puleo DA, Holleran LA, Doremus RH, Bizios R. Osteoblastresponses to orthopedic implant materials in vitro. J BiomedMater Res 1991;25:711–723.
6. Schwartz Z, Lohmann CH, Oefinger J, Bonewald LF, DeanDD, Boyan BD. Implant surface characteristics modulate dif-ferentiation behavior of cells in the osteoblastic lineage. AdvDent Res 1999;13:38–48.
7. Cooper LF. A role for surface topography in creating andmaintaining bone at titanium endosseous implants. J ProsthetDent 2000;84:522–534.
8. Chiesa R, Sandrini E, Santin M, Rondelli G, Cigada A.Osteointegration of titanium and its alloys by anodic on depo-sition and other electrochemical techniques: A review. J ApplBiomater Biomech 2003;1:91–107.
9. Fini M, Cigada A, Rondelli G, Chiesa R, Giardino R. In vitroand in vivo behaviour of a- and P-enriched anodized titanium.Biomaterials 1999;20:1587–1594.
10. Sandrini E, Chiesa R, Rondelli G, Santin M, Cigada A. Anovel biomimetic treatment for an improved osteointegrationof titanium. J Appl Biomater Biomech 2003;1:33–42.
11. Sandrini E, Morris C, Chiesa R, Cigada A, Santin M. In vitroassesment of the osteointegrative potential of a novel multi-phase anodic spark deposition coating for orthopaedic anddental implants. J Biomed Mater Res Part B: Appl Biomater2005;73:392–399.
12. Rodan SB, Imai Y, Chiede MA, Wesolowski G, ThompsonD, Bar-Shavit Z, Shull S, Mann K, Rodan GA. Chracteriza-tion of a human osteosarcoma cell line (Saos-2) with osteo-blastic properties. Cancer Res 1987;47:4961–4966.
13. Marom R, Shur I, Solomon R, Benayahu D. Characterizationof adhesion and differentiation markers of osteogenic marrowstromal cells. J Cell Physiol 2005;48:202–241.
14. Aubin J. Regulation of osteoblast formation and function. RevEndocr Metab Disord 2001;2:81–94.
15. Ducy P, Zhang R, Geoffory V, Ridall AL, Darsenty G. Osf2/Runx2: A transcriptional activator of osteoblastic differentia-tion. Cell 1997;89:747–754.
16. Franceschi RT, Xiao GZ. Regulation of the osteoblst-specifictranscription factor, Runx2: Responsiveness to multiple signaltransduction pathways. J Cell Biochem 2003;88:446–454.
17. Anselme K, Linez P, Bigerelle M, Le Maguer D, Le MaguerA, Hardouin P, Hildebrand HF, Iost A, Leroy JM. The rela-tive influence of the topography and chemistry of TiAl6V4surfaces on osteoblastic cell behaviour. Biomaterials 2000;21:1567–1577.
18. Giordano C, Mandrini E, Del Curto B, Signorelli E, RondelliG, Di Silvio L. Titanium for osteointegration: Comparisonbetween a novel biomimetic treatment and commerciallyexploited surfaces. J Appl Biomater Biomech 2004;2:35–44.
19. Clover J, Gowen M. Are MG63 and HOS TE85 human osteo-sarcoma cell lines representative models of the osteoblasticphenotype? Bone 1994;15:585–591.
20. Ahmad M, McCarthy MB, Gronowicz G. An in vitro modelfor mineralization of human osteoblast-like cells on implantmaterials. Biomaterials 1999;20:211–220.
21. Meyer U, Szulczewski DH, Moeller K, Heide H. Jones DB.Attachment kinetics and differentiation of osteoblasts on dif-ferent biomaterial surfaces. Cells Mater 1993;3:129–140.
22. Stein GR, Lian BJ, Owen TA. Relationship of cell growth tothe regulation of tissue-specific gene expression during osteo-blast differentiation. FASEB J 1990;4:3111–3123.
23. Bai X-C, Liu D, Bai J, Zheng H, Ke Z-Y, Li X-M, Luo S-Q.Oxidative stress inhibits osteoblastic differentiation of bonecells by ERK and NF-kB. Biochem Biophys Res Commun2004;314:197–207.
24. Denhardt DT, Guo X. Osteopontin: A protein with diversefunctions. FASEB J 1993;7:1475–1482.
25. Beck GR, Zerler B, Moran E. Phosphate is a specific signalfor induction of osteopontin gene expression. PNAS 2000;97:8352–8357.
26. Bianco P, Riminucci M, Silvestrini G, Bonucci E, TermineJD, Fisher LW, Robey PG. Localization of bone sialoprotein(BSP) to Golgi and post-Golgi secretory structures in osteo-blasts and to discrete sites in early bone matrix. J HistochemCytochem 1993;41:193–203.
27. Declercq HA, Verbeeck RMH, De Ridder LI, Schacht EH,Cornelissen MJ. Calcification as an indicator of osteoinductivecapacity of biomaterials in osteoblastic cell cultures. Biomate-rials 2005;26:4964–4974.
289GROWTH OF OSTEOBLAST-LIKE CELLS ON ASD-TREATED TITANIUM
Journal of Biomedical Materials Research Part B: Applied Biomaterials